(Q37920717)

25 August 2017

1 reference

title

Pulmonary toxicity of cytotoxic and immunosuppressive agents. A review (English)

1 reference

25 August 2017

0 references

Lehne G

1

1 reference

25 August 2017

Lote K

series ordinal

2

1 reference

25 August 2017

publication date

1 January 1990

1 reference

25 August 2017

1 reference

25 August 2017

volume

29

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

113-124

1 reference

Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

A clinical review of bleomycin--a new antineoplastic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Phase I evaluation of peplomycin with special reference to pulmonary toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Possible anaphylactic reaction to intravenous cyclophosphamide. Report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Hypersensitivity to procarbazine (Matulane®) manifested by fever and pleuropulmonary reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Pulmonary toxicity of antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Noncardiogenic pulmonary edema following injection of methotrexate into the cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Fatal pneumothorax in "BCNU lung".

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Spontaneous Pneumothorax as a Result of Intensive Cytotoxic Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

BCNU (1,3-bis-(2-chloroethyl)-1-nitrosurea) lung. Drug-induced pulmonary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Rapidly progressive, fatal pulmonary fibrosis induced by carmustine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Cyclophosphamide pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Pulmonary disease with chlorambucil therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Multiple pulmonary lesions in a patient treated with BCNU (1,3-BIS(2-chloroethyl)-1-nitrosourea) for glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Fatal pulmonary toxic effects of lomustine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Ultrastructure of pulmonary bleomycin toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Interstitial pulmonary fibrosis, atypical epithelial changes and bronchiolar cell carcinoma following busulfan therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Phase II trial of neocarzinostatin in patients with bladder and prostatic cancer: toxicity of a five-day iv bolus schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Late-onset pulmonary fibrosis and chest deformity in two children treated with cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Cytotoxic drug-induced lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Interstitial Pneumonitis Associated with Azathioprine Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Methotrexate-induced sudden fatal pulmonary reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Large-dose bleomycin therapy and pulmonary toxicity. A possible role of prior radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Lung function in patients receiving busulphan.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Cyclophosphamide-induced interstitial pneumonitis in a patient with ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Early-Onset Cyclophosphamide-Induced Interstitial Pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Cyclophosphamide therapy and interstitial pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Pulmonary fibrosis following therapy with Melphalan for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Methotrexate pneumonitis induced by intrathecal methotrexate therapy: a case report with pharmacokinetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Mitomycin C and vindesine associated pulmonary toxicity with variable clinical expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Phase II evaluation of bleomycin.A Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

An analysis of 40 cases treated by total thoracic irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Antitumour activity and plasma kinetics of bleomycin by continuous and intermittent administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Normal Tissue Responses to Radiation Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Pulmonary toxicity of antineoplastic agents: Anaesthetic and postoperative implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Pulmonary complications after bleomycin, irradiation and surgery for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Synergism of X-rays and bleomycin on Ehrlich ascites tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Generalized urticaria to cyclophosphamide: Type I hypersensitivity to an immunosuppressive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Bleomycin and subsequent anaesthesia: A retrospective study at Vancouver General Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Bleomycin therapy and anaesthesia. The possible hazards of oxygen administration to patients after treatment with bleomycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Central nervous system leukemia and solid tumors of childhood. Treatment with 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Reversibility of severe bleomycin-induced pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

Reversible Interstitial Pneumonitis Associated with Low Dose Bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009126530

10.3109/02841869009126530

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference